Form 8-K - Current report:
SEC Accession No. 0001193125-25-050861
Filing Date
2025-03-10
Accepted
2025-03-10 16:06:06
Documents
13
Period of Report
2025-03-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d938901d8k.htm   iXBRL 8-K 32602
  Complete submission text file 0001193125-25-050861.txt   159041

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtsr-20250307.xsd EX-101.SCH 2878
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtsr-20250307_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtsr-20250307_pre.xml EX-101.PRE 11726
15 EXTRACTED XBRL INSTANCE DOCUMENT d938901d8k_htm.xml XML 3772
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Filer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42489 | Film No.: 25723685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)